genekam logo
  • usa
    • german
    • russia
    • china
Duissern Str. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

04.12.2017
Genekam developed potential therapeutic human anitbodies against Chlamydia

Latest News:

03.11.2017
Genekam has developed a number of new breast cancer tumor markers from blood samples

  • BIO 2018

    Visit us at BIO 2018 in Boston, USA:
    04.06. - 07.06 2018

  • MEDICA 2017

    Visit us at MEDICA in Duesseldorf, Germany:
    13.11.17 - 16.11.17

  • BIO 2018

    Visit us at BIO 2018 in Boston, USA:
    04.06. - 07.06 2018

  • MEDICA 2017

    Visit us at MEDICA in Duesseldorf, Germany:
    13.11.17 - 16.11.17

Antibody Conjugate Therapy

Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.

TOP